Brain, Vol. 123, No. 3, 508-518,
March 2000
© 2000 Oxford University Press
Invited review |
Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects
Epitope spreading versus clonal persistence
1 Department of Neuroimmunology, Max Planck Institute for Neurobiology, Martinsried and 2 Department of Neurology and Institute for Clinical Neuroimmunology, Ludwig-Maximilians University, Munich, Germany
Correspondence to:
Dr Reinhard Hohlfeld, Institute for Clinical Neuroimmunology, Klinikum Grosshadern, Marchioninistrasse 15, D-81366 Munich, Germany E-mail: hohlfeld{at}neuro.mpg.de
Autoantigen-specific T-lymphocytes are present in patients with autoimmune disease and in normal subjects. Little is currently known about the temporal variation (dynamics) of the immune repertoire of these autoreactive T cells. We analysed the long-term variation of the immune repertoire of T cells specific for myelin basic protein (MBP) in five untreated patients with multiple sclerosis and four normal control subjects over a mean observation period of 6 years. MBP-specific CD4+ T-cell lines were selected with purified human MBP, and their epitope specificity was mapped with overlapping synthetic peptides. Three distinct patterns of repertoire development were observed. (i) Two patients and three control subjects maintained a broad epitope response with fluctuations over time. (ii) Two patients initially showed a focused response that broadened over the course of 6 years; this finding could be described as intramolecular epitope spreading. (iii) In one patient and one control subject, a strikingly focused response, which was directed to a cluster of nested epitopes in the MBP region 83–102, persisted over time. T-cell receptor Vß sequence analysis allowed us to trace individual clones of MBP-specific T cells for up to 7 years in the peripheral circulation in four of the five patients and three of the four controls, suggesting that the long-term persistence of MBP-specific T-cell clones is a common feature of the T-cell repertoire not unique to multiple sclerosis. The persisting MBP-specific T-cell clones were not detectable in the blood of one of the patients by complementarity-determining region (CDR)-3 spectratyping, indicating that their frequency does not exceed 1 in 5000 T cells. The temporal characteristics of the MBP-specific T-cell repertoire described here are relevant to therapeutic strategies targeting autoantigen-specific T cells in multiple sclerosis and other autoimmune diseases.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. J. Jung, M. Hur, Y. L. Kim, G. H. Lee, J. Kim, I. Kim, M. Lee, H.-K. Han, M.-S. Kim, S. Hwang, et al. Oral Administration of 1,4-Aryl-2-mercaptoimidazole Inhibits T-Cell Proliferation and Reduces Clinical Severity in the Murine Experimental Autoimmune Encephalomyelitis Model J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 1005 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hong, H. Li, M. Chen, Y. C. Q. Zang, S. M. Skinner, J. M. Killian, and J. Z. Zhang Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis Int. Immunol., December 1, 2009; 21(12): 1329 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Huizinga, R. Q. Hintzen, K. Assink, M. van Meurs, and S. Amor T-cell responses to neurofilament light protein are part of the normal immune repertoire Int. Immunol., April 1, 2009; 21(4): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Verbeek, H. van Dongen, E. F. Wawrousek, S. Amor, and J. M. van Noort Induction of EAE by T cells specific for alpha B-crystallin depends on prior viral infection in the CNS Int. Immunol., March 1, 2007; 19(3): 277 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Ercolini and S. D. Miller Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease J. Immunol., March 15, 2006; 176(6): 3293 - 3298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Deeg, B. Amann, A. J. Raith, and B. Kaspers Inter- and Intramolecular Epitope Spreading in Equine Recurrent Uveitis Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 652 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kawakami, F. Odoardi, T. Ziemssen, M. Bradl, T. Ritter, O. Neuhaus, H. Lassmann, H. Wekerle, and A. Flugel Autoimmune CD4+ T Cell Memory: Lifelong Persistence of Encephalitogenic T Cell Clones in Healthy Immune Repertoires J. Immunol., July 1, 2005; 175(1): 69 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I R Moldovan, R A Rudick, A C Cotleur, S E Born, J-C Lee, M T Karafa, and C M Pelfrey Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing-remitting multiple sclerosis patients Multiple Sclerosis, June 1, 2005; 11(3): 251 - 260. [Abstract] [PDF]
|
|
|
|
|
|
S. Ellmerich, M. Mycko, K. Takacs, H. Waldner, F. N. Wahid, R. J. Boyton, R. H. M. King, P. A. Smith, S. Amor, A. H. Herlihy, et al. High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model J. Immunol., February 15, 2005; 174(4): 1938 - 1946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hohlfeld and H. Wekerle Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines PNAS, October 5, 2004; 101(suppl_2): 14599 - 14606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Crawford, S. X. Yan, S. B. Ortega, R. S. Mehta, R. E. Hewitt, D. A. Price, P. Stastny, D. C. Douek, R. A. Koup, M. K. Racke, et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay Blood, June 1, 2004; 103(11): 4222 - 4231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Skulina, S. Schmidt, K. Dornmair, H. Babbe, A. Roers, K. Rajewsky, H. Wekerle, R. Hohlfeld, and N. Goebels Multiple sclerosis: Brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood PNAS, February 24, 2004; 101(8): 2428 - 2433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Bradl and R Hohlfeld Molecular pathogenesis of neuroinflammation J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1364 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Berger, P. Rubner, F. Schautzer, R. Egg, H. Ulmer, I. Mayringer, E. Dilitz, F. Deisenhammer, and M. Reindl Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event N. Engl. J. Med., July 10, 2003; 349(2): 139 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Veldman, A. Stauber, R. Wassmuth, W. Uter, G. Schuler, and M. Hertl Dichotomy of Autoreactive Th1 and Th2 Cell Responses to Desmoglein 3 in Patients with Pemphigus Vulgaris (PV) and Healthy Carriers of PV-Associated HLA Class II Alleles J. Immunol., January 1, 2003; 170(1): 635 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mizrahi, E. Hauben, and M. Schwartz The Tissue-Specific Self-Pathogen Is the Protective Self-Antigen: The Case of Uveitis J. Immunol., November 15, 2002; 169(10): 5971 - 5977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Weiner, N. Kachuck, W. Gilmore, and B. Lund Immunological aspects of secondary progressive multiple sclerosis Multiple Sclerosis, September 1, 2002; 8(1_suppl): 83 - 84. [PDF]
|
|
|
|
 |
|
 M. Jacobsen, S. Cepok, E. Quak, M. Happel, R. Gaber, A. Ziegler, S. Schock, W. H. Oertel, N. Sommer, and B. Hemmer Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients Brain, March 1, 2002; 125(3): 538 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L P Weiner, N J Kachuck, W Gilmore, and B Lund Immunological aspects of secondary progressive multiple sclerosis Multiple Sclerosis, February 1, 2002; 8(1): 83 - 84. [PDF]
|
|
|
|
|
|
R. K. Burt, S. Slavin, W. H. Burns, and A. M. Marmont Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood, February 1, 2002; 99(3): 768 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Muraro, K.-P. Wandinger, B. Bielekova, B. Gran, A. Marques, U. Utz, H. F. McFarland, S. Jacobson, and R. Martin Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders Brain, January 1, 2002; 126(1): 20 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kipnis, E. Yoles, H. Schori, E. Hauben, I. Shaked, and M. Schwartz Neuronal Survival after CNS Insult Is Determined by a Genetically Encoded Autoimmune Response J. Neurosci., July 1, 2001; 21(13): 4564 - 4571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Babbe, A. Roers, A. Waisman, H. Lassmann, N. Goebels, R. Hohlfeld, M. Friese, R. Schroder, M. Deckert, S. Schmidt, et al. Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction J. Exp. Med., August 7, 2000; 192(3): 393 - 404. [Abstract] [Full Text] [PDF]
|
|